Download PDF
Z Gastroenterol 2011; 49(11): 1489-1490
DOI: 10.1055/s-0031-1281595
Kommentierte Referate

© Georg Thieme Verlag KG Stuttgart · New York

Verbesserung des mittleren Überlebens von Patienten mit neuroendokrinen Karzinomen des Pankreas durch die Behandlung mit molekularen Therapien

Improved Survival in Patients with NET of the Pancreas with Molecular TherapiesT. F. Greten
  • 1National Institutes of Health, National Cancer Institute, Bethesda
Further Information

Publication History





Publication Date:
08 November 2011 (online)

Also available at
    Permissions and Reprints

Raymond E, Dahan L, Raoul JL et al. Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors. N Engl J Med 2011; 364:501 – 513.

Yao JC, Shah MH, Ito T et al. Everolimus for Advanced Pancreatic Neuroendocrine Tumors. N Engl J Med 2011; 364:514 – 523

Tim F. Greten

National Institutes of Health, National Cancer Institute

Building 10 Rm 12N226

9000 Rockville Pike

Bethesda, MD, 20892

USA

Phone:  ++ 1/3 01/4 51 47 23

Fax:  ++ 1/3 01/4 80 87 80

Email: tim.greten@nih.gov

      >